Valuations for API companies witness a surge as global biggies step-up investments
The prices of active pharmaceutical ingredients (APIs) of azithromycin and hydroxychloroquine (HCQ) have increased two to ten times due to sharp rise in their demand to fight against COVID-19 pandemic.
R L Fine Chem News Full Screen View
Market Place
Share